Population pharmacokinetics modelling to predict DDI from zopiclone on clozapine in schizophrenia patients
IntroductionClozapine, as a core drug for the treatment of schizophrenia, is widely used in the drug treatment of schizophrenia patients. However, when multiple drugs are used in combination, it is not clear whether there are drug-drug interactions (DDI) of clozapine in patients with schizophrenia....
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Frontiers Media S.A.
2025-09-01
|
| Ráidu: | Frontiers in Psychiatry |
| Fáttát: | |
| Liŋkkat: | https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1664678/full |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|